abstract |
The invention is concerned with novel cyclic amines of formula (I) wherein X1 to X3, Y1 to Y3, R1’ , R1’’ and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments. |